|
Suppliers for CAS
1187594-09-7
|
Properties | | CAS |
1187594-09-7 | | Formula |
C16H17N7O2S |
|
|
15 Registered suppliers
Amadis Chemical Company Limited
P.R.China
More details are to be found here
Dayang Chem (Hangzhou) Co.,Ltd.
P.R.China
More details are to be found here
Hangzhou Keying Chem Co., Ltd.
P.R.China
More details are to be found here
H&Z Industry Co.,Ltd
P.R.China
More details are to be found here
Xingrui Industry Co., Limited
P.R.China
More details are to be found here
Capot Chemical Co., Ltd.
P.R.China
More details are to be found here
Leap Chem Co., Ltd
P.R.China
Molecular Formula: C16H17N7O2S
Molecular Weight: 371.41688
HS Code: 29350090
Newstar Chem Enterprise Ltd.
P.R.China
Molecular Formula: C16H17N7O2S
Molecular Weight: 371.41688
HS Code: 29350090
Shandong Ench Chemical Co.,Ltd
P.R.China
Molecular Formula: C16H17N7O2S
Molecular Weight: 371.41688
HS Code: 29350090
Aea.ltd
P.R.China
Molecular Formula: C16H17N7O2S
Molecular Weight: 371.41688
HS Code: 29350090
Molecular Formula: C16H17N7O2S
Molecular Weight: 371.41688
HS Code: 29350090
Molecular Formula: C16H17N7O2S
Molecular Weight: 371.41688
HS Code: 29350090
BOC Sciences
USA
Description : Baricitinib is a selective and orally bioactive inhibitor of JAK1 and JAK2. It has been approved by FDA for the treatment of rheumatoid arthritis (RA). - Molecular Weight :371.419
- Boiling Point :707.2±70.0 °C at 760 mmHg
- Melting Point :212-215°C
- Purity :> 98%
Molecular Formula : C16H17N7O2S Canonical SMILES : CCS(=O)(=O)N1CC(C1)(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3
InChI :
InChI=1S/C16H17N7O2S/c1-2-26(24,25)22-9-16(10-22,4-5-17)23-8-12(7-21-23)14-13-3-6-18-15(13)20-11-19-14/h3,6-8,11H,2,4,9-10H2,1H3,(H,18,19,20)
InChIKey :
XUZMWHLSFXCVMG-UHFFFAOYSA-N
Appearance :
White to Off-white Solid
Application :
the treatment of rheumatoid arthritis (RA)
Synonyms :
LY3009104; 2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile; Olumiant
More details are to be found here
Shandong SanYoung Industry Co., Ltd
P.R.China
Description : Baricitinib is a selective and orally bioactive inhibitor of JAK1 and JAK2. It has been approved by FDA for the treatment of rheumatoid arthritis (RA). - Molecular Weight :371.419
- Boiling Point :707.2±70.0 °C at 760 mmHg
- Melting Point :212-215°C
- Purity :> 98%
Molecular Formula : C16H17N7O2S Canonical SMILES : CCS(=O)(=O)N1CC(C1)(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3
InChI :
InChI=1S/C16H17N7O2S/c1-2-26(24,25)22-9-16(10-22,4-5-17)23-8-12(7-21-23)14-13-3-6-18-15(13)20-11-19-14/h3,6-8,11H,2,4,9-10H2,1H3,(H,18,19,20)
InChIKey :
XUZMWHLSFXCVMG-UHFFFAOYSA-N
Appearance :
White to Off-white Solid
Application :
the treatment of rheumatoid arthritis (RA)
Synonyms :
LY3009104; 2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile; Olumiant
More details are to be found here
AK Scientific, Inc.
USA
Description : Baricitinib is a selective and orally bioactive inhibitor of JAK1 and JAK2. It has been approved by FDA for the treatment of rheumatoid arthritis (RA). - Molecular Weight :371.419
- Boiling Point :707.2±70.0 °C at 760 mmHg
- Melting Point :212-215°C
- Purity :> 98%
Molecular Formula : C16H17N7O2S Canonical SMILES : CCS(=O)(=O)N1CC(C1)(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3
InChI :
InChI=1S/C16H17N7O2S/c1-2-26(24,25)22-9-16(10-22,4-5-17)23-8-12(7-21-23)14-13-3-6-18-15(13)20-11-19-14/h3,6-8,11H,2,4,9-10H2,1H3,(H,18,19,20)
InChIKey :
XUZMWHLSFXCVMG-UHFFFAOYSA-N
Appearance :
White to Off-white Solid
Application :
the treatment of rheumatoid arthritis (RA)
Synonyms :
LY3009104; 2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile; Olumiant
More details are to be found here
Chemos GmbH & Co. KG
Germany
Description : Baricitinib is a selective and orally bioactive inhibitor of JAK1 and JAK2. It has been approved by FDA for the treatment of rheumatoid arthritis (RA). - Molecular Weight :371.419
- Boiling Point :707.2±70.0 °C at 760 mmHg
- Melting Point :212-215°C
- Purity :> 98%
Molecular Formula : C16H17N7O2S Canonical SMILES : CCS(=O)(=O)N1CC(C1)(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3
InChI :
InChI=1S/C16H17N7O2S/c1-2-26(24,25)22-9-16(10-22,4-5-17)23-8-12(7-21-23)14-13-3-6-18-15(13)20-11-19-14/h3,6-8,11H,2,4,9-10H2,1H3,(H,18,19,20)
InChIKey :
XUZMWHLSFXCVMG-UHFFFAOYSA-N
Appearance :
White to Off-white Solid
Application :
the treatment of rheumatoid arthritis (RA)
Synonyms :
LY3009104; 2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile; Olumiant
More details are to be found here
Santa Cruz Biotechnology, Inc.
USA
Description : Baricitinib is a selective and orally bioactive inhibitor of JAK1 and JAK2. It has been approved by FDA for the treatment of rheumatoid arthritis (RA). - Molecular Weight :371.419
- Boiling Point :707.2±70.0 °C at 760 mmHg
- Melting Point :212-215°C
- Purity :> 98%
Molecular Formula : C16H17N7O2S Canonical SMILES : CCS(=O)(=O)N1CC(C1)(CC#N)N2C=C(C=N2)C3=C4C=CNC4=NC=N3
InChI :
InChI=1S/C16H17N7O2S/c1-2-26(24,25)22-9-16(10-22,4-5-17)23-8-12(7-21-23)14-13-3-6-18-15(13)20-11-19-14/h3,6-8,11H,2,4,9-10H2,1H3,(H,18,19,20)
InChIKey :
XUZMWHLSFXCVMG-UHFFFAOYSA-N
Appearance :
White to Off-white Solid
Application :
the treatment of rheumatoid arthritis (RA)
Synonyms :
LY3009104; 2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile; Olumiant
More details are to be found here
Detailed information on the suppliers of
|
_Co_Ltd_1_575.jpg){kind=logo}
details
details